An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity
- PMID: 6204766
- DOI: 10.1016/0092-8674(84)90438-0
An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity
Abstract
The v-abl protein is known to be a tyrosine-specific protein kinase. However, its normal cellular homolog, c-abl P150, is not detectably phosphorylated on tyrosine in vivo or in vitro. The lack of associated tyrosine kinase activity for the c-abl protein seems paradoxical since it is the c-abl-derived sequences of the v-abl protein that encode the kinase activity. We have detected an altered human c-abl protein (P210) with associated tyrosine kinase activity in the K562 leukemia cell line. K562 cells are known to have a 9:22 chromosomal translocation involving the c-abl locus and have amplified the c-able gene 4 to 8 fold. The altered P210 human c-abl is serologically and structurally related to the normal c-abl protein. A structural alteration of the human c-abl protein. K562 cells may have unmasked its associated tyrosine kinase activity. This altered c-abl protein may have important implications for a mechanism of activation of this oncogene.
Similar articles
-
Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties.Mol Cell Biol. 1985 Jan;5(1):204-13. doi: 10.1128/mcb.5.1.204-213.1985. Mol Cell Biol. 1985. PMID: 4039028 Free PMC article.
-
Phosphotyrosine antibodies identify the p210c-abl tyrosine kinase and proteins phosphorylated on tyrosine in human chronic myelogenous leukemia cells.Mol Cell Biol. 1986 May;6(5):1803-11. doi: 10.1128/mcb.6.5.1803-1811.1986. Mol Cell Biol. 1986. PMID: 2431286 Free PMC article.
-
Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration.Proc Natl Acad Sci U S A. 1985 Mar;82(6):1810-4. doi: 10.1073/pnas.82.6.1810. Proc Natl Acad Sci U S A. 1985. PMID: 3856862 Free PMC article.
-
Activation of the abl oncogene and its involvement in chromosomal translocations in human leukemia.Mutat Res. 1988 May;195(3):231-43. doi: 10.1016/0165-1110(88)90002-4. Mutat Res. 1988. PMID: 3129652 Review.
-
Role of the ABL oncogene tyrosine kinase activity in human leukaemia.Baillieres Clin Haematol. 1987 Dec;1(4):1001-20. doi: 10.1016/s0950-3536(87)80036-7. Baillieres Clin Haematol. 1987. PMID: 3332851 Review.
Cited by
-
Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS).Leuk Res. 2016 Oct;49:108-12. doi: 10.1016/j.leukres.2016.08.006. Epub 2016 Aug 12. Leuk Res. 2016. PMID: 27658269 Free PMC article.
-
Activation of proto-oncogenes in human leukemias.Blut. 1985 Aug;51(2):63-71. doi: 10.1007/BF00320114. Blut. 1985. PMID: 3896350 Review. No abstract available.
-
The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases.Proc Natl Acad Sci U S A. 1990 Aug;87(15):5802-6. doi: 10.1073/pnas.87.15.5802. Proc Natl Acad Sci U S A. 1990. PMID: 2198571 Free PMC article.
-
The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc.Mol Cell Biol. 1989 Mar;9(3):1263-70. doi: 10.1128/mcb.9.3.1263-1270.1989. Mol Cell Biol. 1989. PMID: 2725497 Free PMC article.
-
Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties.Mol Cell Biol. 1985 Jan;5(1):204-13. doi: 10.1128/mcb.5.1.204-213.1985. Mol Cell Biol. 1985. PMID: 4039028 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous